AZTR
Price
$0.98
Change
-$0.05 (-4.85%)
Updated
Aug 28 closing price
Capitalization
3.45M
81 days until earnings call
RLAY
Price
$3.69
Change
+$0.12 (+3.36%)
Updated
Aug 28 closing price
Capitalization
636.2M
68 days until earnings call
Interact to see
Advertisement

AZTR vs RLAY

Header iconAZTR vs RLAY Comparison
Open Charts AZTR vs RLAYBanner chart's image
Azitra
Price$0.98
Change-$0.05 (-4.85%)
Volume$2.54M
Capitalization3.45M
Relay Therapeutics
Price$3.69
Change+$0.12 (+3.36%)
Volume$811.72K
Capitalization636.2M
AZTR vs RLAY Comparison Chart in %
Loading...
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTR vs. RLAY commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTR is a Buy and RLAY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (AZTR: $0.98 vs. RLAY: $3.69)
Brand notoriety: AZTR and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AZTR: 72% vs. RLAY: 40%
Market capitalization -- AZTR: $3.45M vs. RLAY: $636.2M
AZTR [@Biotechnology] is valued at $3.45M. RLAY’s [@Biotechnology] market capitalization is $636.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTR’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 0 green FA rating(s).

  • AZTR’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 0 green, 5 red.
According to our system of comparison, AZTR is a better buy in the long-term than RLAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTR’s TA Score shows that 5 TA indicator(s) are bullish while RLAY’s TA Score has 6 bullish TA indicator(s).

  • AZTR’s TA Score: 5 bullish, 3 bearish.
  • RLAY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than AZTR.

Price Growth

AZTR (@Biotechnology) experienced а +3.16% price change this week, while RLAY (@Biotechnology) price change was +8.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.07%, and the average quarterly price growth was +29.15%.

Reported Earning Dates

AZTR is expected to report earnings on Nov 18, 2025.

RLAY is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($636M) has a higher market cap than AZTR($3.45M). RLAY YTD gains are higher at: -10.437 vs. AZTR (-65.418). AZTR has higher annual earnings (EBITDA): -8.89M vs. RLAY (-338.15M). AZTR has less debt than RLAY: AZTR (474K) vs RLAY (34.2M). RLAY has higher revenues than AZTR: RLAY (8.36M) vs AZTR (0).
AZTRRLAYAZTR / RLAY
Capitalization3.45M636M1%
EBITDA-8.89M-338.15M3%
Gain YTD-65.418-10.437627%
P/E Ratio0.04N/A-
Revenue08.36M-
Total CashN/A657M-
Total Debt474K34.2M1%
TECHNICAL ANALYSIS
Technical Analysis
AZTRRLAY
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OKLO77.894.69
+6.41%
Oklo Inc.
GEG2.520.12
+4.79%
Great Elm Group
DGLY1.900.02
+1.33%
Digital Ally Inc New
CGON26.720.24
+0.89%
CG Oncology
MAGN12.32-0.14
-1.12%
Magnera Corporation

AZTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTR has been closely correlated with DARE. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if AZTR jumps, then DARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTR
1D Price
Change %
AZTR100%
-4.85%
DARE - AZTR
73%
Closely correlated
+0.25%
PHIO - AZTR
50%
Loosely correlated
-2.46%
SLRX - AZTR
35%
Loosely correlated
-4.54%
SNTI - AZTR
31%
Poorly correlated
-0.64%
RLAY - AZTR
28%
Poorly correlated
+3.36%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+3.36%
XNCR - RLAY
51%
Loosely correlated
+0.37%
IMNM - RLAY
48%
Loosely correlated
-0.50%
RZLT - RLAY
47%
Loosely correlated
+0.28%
BCYC - RLAY
47%
Loosely correlated
+1.14%
SMMT - RLAY
46%
Loosely correlated
-1.55%
More